SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Nov-24 4:38 PM View: | Coach Inc. (TPR) | 14-Nov-24 | Grant | 3,459 | $57.82 | $199,999.00 | 189% 1.83K to 5.29K | |
12-Mar-24 5:43 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Payment of Exercise | 18,522 | $53.79 | $996,298.00 | (8%) 233.15K to 214.63K | |
12-Mar-24 5:43 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Disposition (other) | 19,448 | -- | -- | (9%) 214.63K to 195.18K | |
12-Mar-24 5:43 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Option Exercise | 64,326 | -- | -- | 38% 168.83K to 233.15K | |
01-Mar-24 5:08 PM View: | Coach Inc. (TPR) | 29-Feb-24 | Grant | 1,788 | $47.53 | $84,983.60 | 100% 0 to 1.79K | |
05-Dec-23 6:22 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Dec-23 | Payment of Exercise | 3,730 | $50.10 | $186,873.00 | (2%) 172.56K to 168.82K | |
05-Dec-23 6:22 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Dec-23 | Option Exercise | 8,792 | -- | -- | 5% 163.76K to 172.56K | |
14-Mar-23 8:13 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-23 | Payment of Exercise | 41,331 | $65.71 | $2,715,860.00 | (20%) 205.09K to 163.76K | |
14-Mar-23 8:13 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-23 | Acquisition (other) | 8,930 | -- | -- | 7% 124.29K to 133.22K | |
14-Mar-23 8:13 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-23 | Option Exercise | 71,871 | -- | -- | 54% 133.22K to 205.09K | |
06-Dec-22 6:44 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Dec-22 | Payment of Exercise | 4,498 | $81.13 | $364,923.00 | (3%) 128.78K to 124.29K | |
06-Dec-22 6:44 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Dec-22 | Option Exercise | 8,792 | -- | -- | 7% 119.99K to 128.78K | |
15-Sep-22 7:29 PM View: | Bristol-Myers Squibb Co. (BMY) | 13-Sep-22 | Option Exercise | 123,277 | $48.49 | $5,977,700.00 | 94% 130.66K to 253.94K | |
15-Sep-22 7:29 PM View: | Bristol-Myers Squibb Co. (BMY) | 13-Sep-22 | Option Sale | 123,277 | $71.30 | $8,790,070.00 | (49%) 253.94K to 130.66K | |
15-Sep-22 7:29 PM View: | Bristol-Myers Squibb Co. (BMY) | 13-Sep-22 | Sale | 10,674 | $71.30 | $761,093.00 | (8%) 130.66K to 119.99K | |
14-Mar-22 9:18 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-22 | Payment of Exercise | 9,222 | $68.42 | $630,969.00 | (7%) 139.88K to 130.66K | |
14-Mar-22 9:18 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-22 | Acquisition (other) | 1,962 | -- | -- | 2% 121.85K to 123.82K | |
14-Mar-22 9:18 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-22 | Option Exercise | 16,067 | -- | -- | 13% 123.82K to 139.88K | |
03-Mar-22 5:33 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Mar-22 | Payment of Exercise | 10,381 | $68.63 | $712,448.00 | (8%) 132.24K to 121.85K | |
03-Mar-22 5:33 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Mar-22 | Option Exercise | 24,577 | -- | -- | 23% 107.66K to 132.24K | |
04-Jan-22 6:22 PM View: | Bristol-Myers Squibb Co. (BMY) | 31-Dec-21 | Payment of Exercise | 24,246 | $62.35 | $1,511,740.00 | (18%) 131.9K to 107.66K | |
04-Jan-22 6:22 PM View: | Bristol-Myers Squibb Co. (BMY) | 31-Dec-21 | Option Exercise | 47,401 | -- | -- | 56% 84.5K to 131.9K | |
06-Dec-21 6:27 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Dec-21 | Payment of Exercise | 4,498 | $55.41 | $249,234.00 | (5%) 89.0K to 84.5K | |
06-Dec-21 6:27 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Dec-21 | Option Exercise | 8,792 | -- | -- | 11% 80.21K to 89.0K | |
16-Aug-21 5:51 PM View: | Bristol-Myers Squibb Co. (BMY) | 12-Aug-21 | Option Exercise | 70,000 | $48.49 | $3,394,300.00 | 64% 109.9K to 179.9K | |
16-Aug-21 5:51 PM View: | Bristol-Myers Squibb Co. (BMY) | 12-Aug-21 | Market Option Sale | 70,000 | $66.95 | $4,686,630.00 | (39%) 179.9K to 109.9K | |
16-Aug-21 5:51 PM View: | Bristol-Myers Squibb Co. (BMY) | 12-Aug-21 | Market Sale | 29,691 | $66.95 | $1,987,870.00 | (27%) 109.9K to 80.21K | |
03-Aug-21 10:00 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Aug-21 | Payment of Exercise | 23,736 | $67.87 | $1,610,960.00 | (18%) 133.63K to 109.9K | |
03-Aug-21 10:00 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Aug-21 | Option Exercise | 46,403 | -- | -- | 53% 87.23K to 133.63K | |
12-Mar-21 6:57 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-21 | Payment of Exercise | 4,329 | $60.93 | $263,766.00 | (5%) 91.56K to 87.23K | |
12-Mar-21 6:57 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-21 | Acquisition (other) | 150 | -- | -- | < 1% 83.38K to 83.53K | |
12-Mar-21 6:57 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-21 | Option Exercise | 8,025 | -- | -- | 10% 83.53K to 91.56K | |
03-Mar-21 5:27 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Mar-21 | Payment of Exercise | 8,573 | $61.63 | $528,354.00 | (9%) 91.95K to 83.38K | |
03-Mar-21 5:27 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Mar-21 | Option Exercise | 24,579 | -- | -- | 36% 67.38K to 91.95K | |
05-Jan-21 8:13 PM View: | Bristol-Myers Squibb Co. (BMY) | 31-Dec-20 | Payment of Exercise | 11,931 | $62.03 | $740,080.00 | (15%) 79.31K to 67.38K | |
05-Jan-21 8:13 PM View: | Bristol-Myers Squibb Co. (BMY) | 31-Dec-20 | Option Exercise | 20,624 | -- | -- | 35% 58.68K to 79.31K | |
03-Dec-20 8:24 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Dec-20 | Payment of Exercise | 5,087 | $62.18 | $316,310.00 | (8%) 63.77K to 58.68K | 1% |
03-Dec-20 8:24 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Dec-20 | Option Exercise | 8,792 | -- | -- | 16% 54.98K to 63.77K | |
04-Aug-20 4:43 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Aug-20 | Payment of Exercise | 25,916 | $58.66 | $1,520,230.00 | (32%) 80.89K to 54.98K | (4%) |
04-Aug-20 4:43 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Aug-20 | Option Exercise | 46,402 | -- | -- | 135% 34.49K to 80.89K | |
03-Mar-20 8:04 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Mar-20 | Payment of Exercise | 10,470 | $59.06 | $618,358.00 | (23%) 44.96K to 34.49K | (2%) |
03-Mar-20 8:04 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Mar-20 | Option Exercise | 24,579 | -- | -- | 121% 20.38K to 44.96K | |
03-Jan-20 7:00 PM View: | Bristol-Myers Squibb Co. (BMY) | 31-Dec-19 | Payment of Exercise | 6,094 | $64.19 | $391,174.00 | (23%) 26.48K to 20.38K | 7% |
03-Jan-20 7:00 PM View: | Bristol-Myers Squibb Co. (BMY) | 31-Dec-19 | Option Exercise | 12,373 | -- | -- | 88% 14.1K to 26.48K | |
27-Nov-19 5:56 PM View: | Bristol-Myers Squibb Co. (BMY) | 20-Nov-19 | Grant | 13,908 | -- | -- | 100% 0 to 13.91K | |
27-Nov-19 5:56 PM View: | Bristol-Myers Squibb Co. (BMY) | 20-Nov-19 | Grant | 195 | -- | -- | 1% 13.91K to 14.1K | |
22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Grant | 43,224 | -- | -- | 306% 14.1K to 57.33K | |
22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 57,132 | -- | -- | (100%) 57.33K to 0.2K | |
22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 195 | -- | -- | (100%) 0.2K to 0 | |
05-Aug-19 4:00 PM View: | Celgene Corporation (CELG) | 01-Aug-19 | Payment of Exercise | 11,039 | $93.05 | $1,027,180.00 | (44%) 25.14K to 14.1K |